Cencora (COR) Competitors

Cencora (NYSE:COR) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, earnings, analyst recommendations and dividends.

Do analysts rate COR or ELV?

Cencora currently has a consensus target price of $311.25, suggesting a potential upside of 6.47%. Elevance Health has a consensus target price of $411.06, suggesting a potential upside of 33.95%. Given Elevance Health's higher probable upside, analysts clearly believe Elevance Health is more favorable than Cencora.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cencora	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.75
Elevance Health	0 Sell rating(s)	6 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.67

Which has stronger valuation & earnings, COR or ELV?

Elevance Health has lower revenue, but higher earnings than Cencora. Elevance Health is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cencora	$293.96B	0.19	$1.51B	$9.72	30.08
Elevance Health	$177.01B	0.39	$5.98B	$23.50	13.06

Is COR or ELV a better dividend stock?

Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.8%. Elevance Health pays an annual dividend of $6.84 per share and has a dividend yield of 2.2%. Cencora pays out 22.6% of its earnings in the form of a dividend. Elevance Health pays out 29.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cencora has raised its dividend for 15 consecutive years and Elevance Health has raised its dividend for 14 consecutive years.

Do insiders and institutionals hold more shares of COR or ELV?

97.5% of Cencora shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 10.8% of Cencora shares are held by insiders. Comparatively, 0.3% of Elevance Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Which has more risk & volatility, COR or ELV?

Cencora has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500.

Is COR or ELV more profitable?

Elevance Health has a net margin of 2.83% compared to Cencora's net margin of 0.60%. Cencora's return on equity of 267.36% beat Elevance Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cencora	0.60%	267.36%	4.31%
Elevance Health	2.83%	17.59%	6.36%

Does the media refer more to COR or ELV?

In the previous week, Cencora and Cencora both had 36 articles in the media. Cencora's average media sentiment score of 1.56 beat Elevance Health's score of 1.36 indicating that Cencora is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cencora	31 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Elevance Health	29 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Cencora beats Elevance Health on 10 of the 18 factors compared between the two stocks.